Evidence map›Paper›PMID 36960709›Full record

ArticleYeast (Chichester, England)2023

TorC1 and nitrogen catabolite repression control of integrated GABA shunt and retrograde pathway gene expression.

Jennifer J Tate, Rajendra Rai, Terrance G Cooper

Abstract read
In one paragraph

Article in Yeast (Chichester, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jennifer J TateDepartment of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Rajendra RaiDepartment of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Terrance G CooperDepartment of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Funding

SYNTHESIS AND ASSEMBLY OF EUKARYOTIC MEMBRANESR01GM035642 · NIGMS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI COOPER, TERRANCE G. · 1985 to 2015
$4.3M
NIGMS NIH HHS R01 GM035642
6 · The paper itself

Abstract

Despite our detailed understanding of how the lower GABA shunt and retrograde genes are regulated, there is a paucity of validated information concerning control of GAD1, the glutamate decarboxylase gene which catalyzes the first reaction of the GABA shunt. Further, integration of glutamate degradation via the GABA shunt has not been investigated. Here, we show that while GAD1 shares a response to rapamycin-inhibition of the TorC1 kinase, it does so independently of the Gln3 and Gat1 NCR-sensitive transcriptional activators that mediate transcription of the lower GABA shunt genes. We also show that GABA shunt gene expression increases dramatically in response to nickel ions. The α-ketoglutarate needed for the GABA shunt to cycle, thereby producing reduced pyridine nucleotides, derives from the retrograde pathway as shown by a similar high increase in the retrograde reporter, CIT2 when nickel is present in the medium. These observations demonstrate high integration of the GABA shunt, retrograde, peroxisomal glyoxylate cycle, and β-oxidation pathways.

Indexed as

Catabolite RepressionSaccharomyces cerevisiae Proteinsgamma-Aminobutyric AcidGATA Transcription FactorsGene ExpressionMechanistic Target of Rapamycin Complex 1NickelNitrogenSaccharomyces cerevisiaegamma-Aminobutyric AcidGATA Transcription FactorsMechanistic Target of Rapamycin Complex 1NickelNitrogenSaccharomyces cerevisiae ProteinsGABA shuntGAD1Gln3retrograde pathwayTorC1UGA1

Identifiers

PMID36960709
PMCPMC10518031

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.